Ana Echegoyen-Silanes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana Echegoyen-Silanes has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Andreina Stefanía De Oliveira
Servicio Navarro de Salud-Osasunbidea. Hospital Universitario de Navarra. Servicio de Anatomía Patológica. Pamplona. España
1 shared publication - Beatriz Sobrino
Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III
1 shared publication - Begoña Álvarez
Servicio Navarro de Salud-Osasunbidea. Hospital Universitario de Navarra. Servicio de Radiología. Pamplona. España
1 shared publication - Clara Ruiz-Ponte
Fundación Pública Galega de Medicina Xenómica (SERGAS), Instituto de Investigación Sanitaria de Santiago, GMX-University of Santiago de Compostela, Santiago de Compostela, Spain
1 shared publication - Elena Almudévar
Servicio Navarro de Salud-Osasunbidea. Hospital Universitario de Navarra. Servicio de Anatomía Patológica. Pamplona. España
1 shared publication - Emma Anda
Department of Endocrinology and Nutrition, Complejo Hospitalario de Navarra, 31008 Pamplona, Spain
1 shared publication
Latest Publications
- Open Access
- 3 October 2025
- Published by Gobierno de Navarra in Anales del Sistema Sanitario de Navarra
- Vol. 48 (3) , e1137
Histiocitosis de células de Langerhans diagnosticada en ganglios mediastínicos mediante punción-aspiración con aguja fina guiada por ecobroncoscopia
Varón de 57 años de edad, fumador, al que se le realiza punción aspiración con aguja fina guiada por ecobroncoscopia por presentar adenopatías hipercaptantes en la tomografía por emisión de positrones. La citopatóloga procesó in situ extensiones citológicas para evaluación rápida (Diff-Quick) y diferida (Papanicolaou). Con los fragmentos sólidos y los coágulos obtenidos realizó un bloque celular que se procesó como biopsia. En las extensiones se observaron células de aspecto histiocitoide con núcleos hendidos, inmunorreactivas para CD68, CD1a, Langerina y S100, con abundantes eosinófilos; el diagnóstico final fue de histiocitosis de células de Langerhans. El diagnóstico citológico preciso de esta entidad en ganglios mediastínicos supone un gran reto. Este caso queremos resaltar que un buen manejo del material por el citopatólogo presente en la sala es clave para rentabilizar el tejido y poder realizar las técnicas complementarias necesarias para un diagnóstico completo, evitando abordajes diagnósticos más agresivos.
- 3 October 2025
- Published by Gobierno de Navarra in Anales del Sistema Sanitario de Navarra
- Vol. 48 (3) , e1137
Open AccessHistiocitosis de células de Langerhans diagnosticada en ganglios mediastínicos mediante punción-aspiración con aguja fina guiada por ecobroncoscopia
Varón de 57 años de edad, fumador, al que se le realiza punción aspiración con aguja fina guiada por ecobroncoscopia por presentar adenopatías hipercaptantes en la tomografía por emisión de positrones. La citopatóloga procesó in situ extensiones citológicas para evaluación rápida (Diff-Quick) y diferida (Papanicolaou). Con los fragmentos sólidos y los coágulos obtenidos realizó un bloque celular que se procesó como biopsia. En las extensiones se observaron células de aspecto histiocitoide con núcleos hendidos, inmunorreactivas para CD68, CD1a, Langerina y S100, con abundantes eosinófilos; el diagnóstico final fue de histiocitosis de células de Langerhans. El diagnóstico citológico preciso de esta entidad en ganglios mediastínicos supone un gran reto. Este caso queremos resaltar que un buen manejo del material por el citopatólogo presente en la sala es clave para rentabilizar el tejido y poder realizar las técnicas complementarias necesarias para un diagnóstico completo, evitando abordajes diagnósticos más agresivos.
- Open Access
- 23 January 2023
- Published by Springer Nature in Virchows Archiv
- Vol. 482 (3) , 615-623
Cribriform morular thyroid carcinoma: a case report with pathological, immunohistochemical, and molecular findings suggesting an origin from follicular cells (or their endodermal precursors)
Cribriform morular thyroid carcinoma (CMTC) is a rare malignant thyroid tumor with a peculiar growth pattern secondary to permanent activation of the WNT/β-catenin pathway. CMTC may be associated with familial adenomatous polyposis or sporadic; it shares morphological features with papillary thyroid carcinoma (PTC) and was considered a variant of PTC in the 2017 WHO classification of tumors of endocrine organs. The new 5th edition of the WHO classification of endocrine and neuroendocrine tumors considered CMTC an independent thyroid neoplasm of uncertain histogenesis. A thymic/ultimobranchial pouch-related differentiation in CMTC has been recently postulated. We, however, have used the pathological and immunohistochemical features of this case of CMTC with 2 novel oncogenic somatic variants (c.3428_3429insA, p.(Tyr1143Ter) and c.3565del, p. (Ser1189Hisfs*76) of the APC gene to propose an origin from follicular cells (or their endodermal precursors). As usual in CMTC, the morular component of this tumor was positive for CDX2. Given the fact that WNT/β-catenin signaling, through CDX2, activates large intestine and small intestine gene expression, we postulate that in CMTC, the tumor cells have their terminal differentiation blocked, thus showing a peculiar primitive endodermal (intestinal-like) phenotype negative for sodium-iodide symporter, thyroperoxidase, and thyroglobulin. Establishing the histogenesis of CMTC is very relevant for the development of appropriate therapies of redifferentiation, particularly in patients where the tumor cannot be controlled by surgery.
- 23 January 2023
- Published by Springer Nature in Virchows Archiv
- Vol. 482 (3) , 615-623
Open AccessCribriform morular thyroid carcinoma: a case report with pathological, immunohistochemical, and molecular findings suggesting an origin from follicular cells (or their endodermal precursors)
Cribriform morular thyroid carcinoma (CMTC) is a rare malignant thyroid tumor with a peculiar growth pattern secondary to permanent activation of the WNT/β-catenin pathway. CMTC may be associated with familial adenomatous polyposis or sporadic; it shares morphological features with papillary thyroid carcinoma (PTC) and was considered a variant of PTC in the 2017 WHO classification of tumors of endocrine organs. The new 5th edition of the WHO classification of endocrine and neuroendocrine tumors considered CMTC an independent thyroid neoplasm of uncertain histogenesis. A thymic/ultimobranchial pouch-related differentiation in CMTC has been recently postulated. We, however, have used the pathological and immunohistochemical features of this case of CMTC with 2 novel oncogenic somatic variants (c.3428_3429insA, p.(Tyr1143Ter) and c.3565del, p. (Ser1189Hisfs*76) of the APC gene to propose an origin from follicular cells (or their endodermal precursors). As usual in CMTC, the morular component of this tumor was positive for CDX2. Given the fact that WNT/β-catenin signaling, through CDX2, activates large intestine and small intestine gene expression, we postulate that in CMTC, the tumor cells have their terminal differentiation blocked, thus showing a peculiar primitive endodermal (intestinal-like) phenotype negative for sodium-iodide symporter, thyroperoxidase, and thyroglobulin. Establishing the histogenesis of CMTC is very relevant for the development of appropriate therapies of redifferentiation, particularly in patients where the tumor cannot be controlled by surgery.